Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PRM | DD |
|---|---|---|
| Price | $28.07 | $130.69 |
| Change today | ▲ 2.26% | ▲ 0.55% |
| Market cap | $4.59B | $17.65B |
| Return, 3 months | -16.1% | -5.7% |
| Return, year to date | +2.0% | +10.0% |
| Return, 1 year | +22.6% | +30.3% |
| P/E (TTM) | -12.6 | 326.7 |
| P/B | 4.5 | 1.3 |
| P/E percentile vs own 5y | 27th | 98th |
| Dividend yield | – | 2.32% |
| Revenue growth (YoY, latest qtr) | – | +4.0% |
| Net profit growth (YoY) | – | +110.0% |
| Gross margin | – | 35.1% |
| Operating margin | – | 13.6% |
| Net margin | – | 0.8% |
| Return on equity | – | 0.3% |
| Analyst target vs. price | +46.1% | +29.0% |
| Analyst buy share | 100% | 75% |
| RSI (14) | 41 | 48 |
| 30-day volatility | 43.0% | 18.6% |
| Max drawdown, 1 year | -30.3% | -18.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
